# Microbiome and Association With Implant Infections

> **NCT05020574** · PHASE2 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer
- Breast Cancer Female
- Genetic Predisposition to Disease

## Interventions

- **DRUG:** Cephalexin

## Key facts

- **NCT ID:** NCT05020574
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020574, "Microbiome and Association With Implant Infections". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05020574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*